Previous close | 2.1500 |
Open | 2.2050 |
Bid | 2.2050 x 0 |
Ask | 2.2950 x 0 |
Day's range | 2.2050 - 2.2800 |
52-week range | 1.6000 - 4.5000 |
Volume | |
Avg. volume | 1,147 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
We can readily understand why investors are attracted to unprofitable companies. For example, although...
AC Immune SA ( NASDAQ:ACIU ) shareholders should be happy to see the share price up 17% in the last month. But over the...
Robert Michael is set to succeed Richard A. Gonzalez as AbbVie's (ABBV) CEO, effective Jul 1, 2024.